Eagle Pharmaceuticals, Inc. Proceeds from Long-Term Debt Issued
Eagle Pharmaceuticals, Inc. reported Proceeds from Long-Term Debt Issued of $50.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-03-23
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-12-31 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-09-30 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-06-30 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $50.00M.
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2021 was $0.00.
- Eagle Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $50.00M 10-K · filed 2023-03-23 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $0.00 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | -$110.00M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | -$110.00M derived: sum of 3 quarters · filed 2023-03-23 | -$110.00M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | -$110.00M derived: sum of 2 quarters · filed 2023-03-23 | -$110.00M derived: sum of 3 quarters · filed 2023-03-23 | -$110.00M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | -$110.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$110.00M derived: sum of 2 quarters · filed 2023-03-23 | -$110.00M derived: sum of 3 quarters · filed 2023-03-23 | $0.00 10-K · filed 2023-03-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $110.00M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $110.00M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $110.00M 10-Q · filed 2021-05-10 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $0.00 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | |||
| 2017-09-30 | $50.00M 10-Q · filed 2018-11-01 | |||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-08 |